Krishnamoorthy Venkateskumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Krishnamoorthy Venkateskumar has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Subramani Parasuraman
Unit of Pharmacology, Toxicology and Basic Health Sciences, Faculty of Pharmacy, AIMST University, Bedong, Kedah Darul Aman, Malaysia
4 shared publications - Heng Wei Kai
Clinical Pharmacy Unit, Faculty of Pharmacy, AIMST University, Bedong, Kedah, Malaysia
2 shared publications Krishnan Sureshkumar
KMCH College of Pharmacy, Kovai Estate, Kalapatty Road, Coimbatore, Tamil Nadu, India
2 shared publicationsLeow Yu Chuen
Department of Pharmaceutical Technology, Faculty of Pharmacy, AIMST University, Semeling, Malaysia
2 shared publicationsRaju Gunasunderi
School of Distance Learning, Universiti Sains Malaysia (USM), Pulau, Penang, Malaysia
2 shared publicationsSubramani Parasuraman
Faculty of Pharmacy, AIMST University, Jalan Bedong-Semeling, 08100 Bedong, Kedah. Malaysia
2 shared publications
Latest Publications
- 8 September 2020
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 17 (4) , 507-514
Exploring Antimicrobials from the Flora and Fauna of Marine: Opportunities and Limitations
About 95% of earth living space lies deep below the ocean’s surface and it harbors extraordinary diversity of marine organisms. Marine biodiversity is an exceptional reservoir of natural products, bioactive compounds, nutraceuticals and other potential compounds of commercial value. Timeline for the development of the drug from a plant, synthetic and other alternative sources is too lengthy. Exploration of the marine environment for potential bioactive compounds has gained focus and huge opportunity lies ahead for the exploration of such vast resources in the ocean. Further, the evolution of superbugs with increasing resistance to the currently available drugs is alarming and it needs coordinated efforts to resolve them. World Health Organization recommends the need and necessity to develop effective bioactive compounds to combat problems associated with antimicrobial resistance. Based on these factors, it is imperative to shift the focus towards the marine environment for potential bioactive compounds that could be utilized to tackle antimicrobial resistance. Current research trends also indicate the huge strides in research involving marine environment for drug discovery. The objective of this review article is to provide an overview of marine resources, recently reported research from marine resources, challenges, future research prospects in the marine environment.
- 8 September 2020
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 17 (4) , 507-514
Exploring Antimicrobials from the Flora and Fauna of Marine: Opportunities and Limitations
About 95% of earth living space lies deep below the ocean’s surface and it harbors extraordinary diversity of marine organisms. Marine biodiversity is an exceptional reservoir of natural products, bioactive compounds, nutraceuticals and other potential compounds of commercial value. Timeline for the development of the drug from a plant, synthetic and other alternative sources is too lengthy. Exploration of the marine environment for potential bioactive compounds has gained focus and huge opportunity lies ahead for the exploration of such vast resources in the ocean. Further, the evolution of superbugs with increasing resistance to the currently available drugs is alarming and it needs coordinated efforts to resolve them. World Health Organization recommends the need and necessity to develop effective bioactive compounds to combat problems associated with antimicrobial resistance. Based on these factors, it is imperative to shift the focus towards the marine environment for potential bioactive compounds that could be utilized to tackle antimicrobial resistance. Current research trends also indicate the huge strides in research involving marine environment for drug discovery. The objective of this review article is to provide an overview of marine resources, recently reported research from marine resources, challenges, future research prospects in the marine environment.
- 1 January 2019
- Published by SAGE Publications in Pharmacognosy Magazine
- Vol. 15 (66) , 402-409
Exploration of antioxidant capacity of extracts of Perna viridis, a marine bivalve
Background: The biopotential of Malaysian green mussels (Perna viridis) has not been fully explored. The aim of the study is to screen the antioxidant capacity of extracts of Malaysian green mussels. Materials and Methods: Mussels were extracted by using solvents such as water, methanol, and ethanol, and methods such as microwave-assisted extraction (MAE) and animal tissue homogenization (ATH) were employed. The percentage yield, total protein content (TPC), total phenolic content, trace element analysis, and biochemical screening of extracts were carried out. The antioxidant capacity of the extracts was assessed by 2,2,-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) assay, 2,2'-azino-bis[3-ethylbenzothiazoline-6-sulfonic acid] (ABTS) assay, hydrogen peroxide scavenging assay, and ferric-reducing antioxidant power (FRAP) methods. Results: The yield of extracts prepared by MAE methods was higher than the extracts prepared by ATH methods. The total phenolic contents and TPC were higher in the extracts prepared by ATH method than those prepared by MAE methods. Biochemical screening results revealed the presence of alkaloids, phenolic compounds, and saponins. The percentage radical scavenging and inhibitory concentration50(IC50) values of all extracts were found to be lesser than the standard. Results showed that extracts by ATH methods displayed high antioxidant activity than extracts by MAE methods. The methanolic extracts of P. viridis showed better antioxidant capacity than other extracts in DPPH and ABTS assay methods, whereas the ethanolic extracts displayed high antioxidant activity than other extracts in hydrogen peroxide and FRAP assay methods. The antioxidant activity of the extracts could be attributed to the hydrogen-donating ability of bioactive peptides, phenolic compounds, alkaloids, reducing sugars, and trace elements present in such extracts. Conclusion: The results of the present study lay the platform to isolate newer antioxidants from Malaysian green mussels. It is concluded that extensive mechanistic studies are imminent to ascertain the molecular mechanism involved in the antioxidant activity of such extracts.
- 1 January 2019
- Published by SAGE Publications in Pharmacognosy Magazine
- Vol. 15 (66) , 402-409
Exploration of antioxidant capacity of extracts of Perna viridis, a marine bivalve
Background: The biopotential of Malaysian green mussels (Perna viridis) has not been fully explored. The aim of the study is to screen the antioxidant capacity of extracts of Malaysian green mussels. Materials and Methods: Mussels were extracted by using solvents such as water, methanol, and ethanol, and methods such as microwave-assisted extraction (MAE) and animal tissue homogenization (ATH) were employed. The percentage yield, total protein content (TPC), total phenolic content, trace element analysis, and biochemical screening of extracts were carried out. The antioxidant capacity of the extracts was assessed by 2,2,-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) assay, 2,2'-azino-bis[3-ethylbenzothiazoline-6-sulfonic acid] (ABTS) assay, hydrogen peroxide scavenging assay, and ferric-reducing antioxidant power (FRAP) methods. Results: The yield of extracts prepared by MAE methods was higher than the extracts prepared by ATH methods. The total phenolic contents and TPC were higher in the extracts prepared by ATH method than those prepared by MAE methods. Biochemical screening results revealed the presence of alkaloids, phenolic compounds, and saponins. The percentage radical scavenging and inhibitory concentration50(IC50) values of all extracts were found to be lesser than the standard. Results showed that extracts by ATH methods displayed high antioxidant activity than extracts by MAE methods. The methanolic extracts of P. viridis showed better antioxidant capacity than other extracts in DPPH and ABTS assay methods, whereas the ethanolic extracts displayed high antioxidant activity than other extracts in hydrogen peroxide and FRAP assay methods. The antioxidant activity of the extracts could be attributed to the hydrogen-donating ability of bioactive peptides, phenolic compounds, alkaloids, reducing sugars, and trace elements present in such extracts. Conclusion: The results of the present study lay the platform to isolate newer antioxidants from Malaysian green mussels. It is concluded that extensive mechanistic studies are imminent to ascertain the molecular mechanism involved in the antioxidant activity of such extracts.
- Open Access
- 15 February 2018
- Published by Manuscript Technomedia LLP in Journal of Young Pharmacists
- Vol. 10 (1) , 01-02
Does Electromagnetic Radiation affect drug stability?
Stability is one of the key determinant in assessing the quality, safety and efficacy of Active Pharmaceutical Ingredient (API) or Finished Pharmaceutical Product (FPP). Stability issues in a pharmaceutical products could result in physical, chemical changes in the finished products. Such degraded products could lead to treatment inefficiency, development of mild to severe adverse reactions in consumer, monetary loss and regulatory noncompliance. The stability of any API or FPP could be influenced by temperature, humidity, direct sun light, changes in storage conditions, frequency of single unit dispensing from bulk package, and other radiation related factors. Temperature is one of the key physical factors which affects drug stability and potency. For example, storage of insulin at 32˚C and above lose its potency after two weeks and on cold storage retains its potency for more than three weeks.1 Few of the pharmaceutical formulations are advised to store it in amber colour containers to prevent its degradation by direct sun light. It should be observed that the radiation related factors are expected to play a major role in affecting the stability of FPPs. The radiation related factors includes radiation from cellular towers, smart phones, mobiles, Wi-Fi supporting devices, electronic gadgets, particle radiation, acoustic radiation and gravitational radiation may also affect the stability of FPP. The effects of radiation gains much significance specifically in the current digital world, because the digital devices have become a part of our daily routine life. The effect of various radiation factors on the stability of APIs or FPPs is a major area of health concern that has to be given due importance. The current guidelines on stability assessments have not incorporated the effects of these radiations on APIs or FPPs. It is essential to study the effect of radiations on stability of any formulation to ensure it’s safety Read more...
- 15 February 2018
- Published by Manuscript Technomedia LLP in Journal of Young Pharmacists
- Vol. 10 (1) , 01-02
Open AccessDoes Electromagnetic Radiation affect drug stability?
Stability is one of the key determinant in assessing the quality, safety and efficacy of Active Pharmaceutical Ingredient (API) or Finished Pharmaceutical Product (FPP). Stability issues in a pharmaceutical products could result in physical, chemical changes in the finished products. Such degraded products could lead to treatment inefficiency, development of mild to severe adverse reactions in consumer, monetary loss and regulatory noncompliance. The stability of any API or FPP could be influenced by temperature, humidity, direct sun light, changes in storage conditions, frequency of single unit dispensing from bulk package, and other radiation related factors. Temperature is one of the key physical factors which affects drug stability and potency. For example, storage of insulin at 32˚C and above lose its potency after two weeks and on cold storage retains its potency for more than three weeks.1 Few of the pharmaceutical formulations are advised to store it in amber colour containers to prevent its degradation by direct sun light. It should be observed that the radiation related factors are expected to play a major role in affecting the stability of FPPs. The radiation related factors includes radiation from cellular towers, smart phones, mobiles, Wi-Fi supporting devices, electronic gadgets, particle radiation, acoustic radiation and gravitational radiation may also affect the stability of FPP. The effects of radiation gains much significance specifically in the current digital world, because the digital devices have become a part of our daily routine life. The effect of various radiation factors on the stability of APIs or FPPs is a major area of health concern that has to be given due importance. The current guidelines on stability assessments have not incorporated the effects of these radiations on APIs or FPPs. It is essential to study the effect of radiations on stability of any formulation to ensure it’s safety Read more...
- 1 January 2017
- Published by Medknow in Journal of Pharmaceutical Negative Results
- Vol. 8 (1) , 37
Investigation of mast cell stabilization and antiulcer activity of protein extract of Perna viridis
Objective: To study the mast cell stabilization and antiucler activity of protein extract of Perna viridis using rodent models. Materials and Methods: The total protein from P. viridis was extracted, purified, and screened for mast cell stabilization and antiulcer activity. Intestinal mesentery of male rats was used to study the peritoneal mast cell stabilization of protein extract of P. viridis. The rat intestinal mesentery was exposed to 10, 30, 100, 300, and 600 μg/mL of protein extract of P. viridis and the peritoneal mast cell stabilization was compared with that of standard (ketotifen) at a dose of 20 μg/mL. Antiulcer activity of protein extract of P. viridis was studied at the dose levels of 100, 200, and 400 mg/kg and the effect was compared with the omeprazole (20 mg/kg) using ethanol-induced ulcer model. At the end of the study, ulcer index and percentage of ulcer inhibition was calculated. Results: The total protein content in extract was found to be 32 μg/mL. The protein extracts of P. viridis showed significant mast cell stabilization only at high dose (600 μg/mL) and did not show any significant antiulcer activity for doses of 100 and 200 mg/kg in administered animals, but the significant antiulcer activity was observed at a dose of 400 mg/kg. Conclusion: The present study findings suggests that the protein extract of P. viridis did not exhibited significant mast cell stabilization and antiulcer activity at optimal doses.
- 1 January 2017
- Published by Medknow in Journal of Pharmaceutical Negative Results
- Vol. 8 (1) , 37
Investigation of mast cell stabilization and antiulcer activity of protein extract of Perna viridis
Objective: To study the mast cell stabilization and antiucler activity of protein extract of Perna viridis using rodent models. Materials and Methods: The total protein from P. viridis was extracted, purified, and screened for mast cell stabilization and antiulcer activity. Intestinal mesentery of male rats was used to study the peritoneal mast cell stabilization of protein extract of P. viridis. The rat intestinal mesentery was exposed to 10, 30, 100, 300, and 600 μg/mL of protein extract of P. viridis and the peritoneal mast cell stabilization was compared with that of standard (ketotifen) at a dose of 20 μg/mL. Antiulcer activity of protein extract of P. viridis was studied at the dose levels of 100, 200, and 400 mg/kg and the effect was compared with the omeprazole (20 mg/kg) using ethanol-induced ulcer model. At the end of the study, ulcer index and percentage of ulcer inhibition was calculated. Results: The total protein content in extract was found to be 32 μg/mL. The protein extracts of P. viridis showed significant mast cell stabilization only at high dose (600 μg/mL) and did not show any significant antiulcer activity for doses of 100 and 200 mg/kg in administered animals, but the significant antiulcer activity was observed at a dose of 400 mg/kg. Conclusion: The present study findings suggests that the protein extract of P. viridis did not exhibited significant mast cell stabilization and antiulcer activity at optimal doses.
- 21 December 2016
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 18 (6) , 2085-2094
Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights
The dissolution and subsequent oral bioavailability of acyclovir (ACY) is limited by its poor aqueous solubility. An attempt has been made in this work to provide mechanistic insights into the solubility enhancement and dissolution of ACY by using the water-soluble carrier polyethylene glycol 6000 (PEG6000). Solid dispersions with varying ratios of the drug (ACY) and carrier (PEG6000) were prepared and evaluated by phase solubility, in vitro release studies, kinetic analysis, in situ perfusion, and in vitro permeation studies. Solid state characterization was done by powder X-ray diffraction (XRD), differential scanning calorimetry (DSC), and Fourier transform infrared (FTIR) analysis, and surface morphology was assessed by polarizing microscopic image analysis, scanning electron microscopy, atomic force microscopy, and nuclear magnetic resonance analysis. Thermodynamic parameters indicated the solubilization effect of the carrier. The aqueous solubility and dissolution of ACY was found to be higher in all samples. The findings of XRD, DSC, FTIR and NMR analysis confirmed the formation of solid solution, crystallinity reduction, and the absence of interaction between the drug and carrier. SEM and AFM analysis reports ratified the particle size reduction and change in the surface morphology in samples. The permeation coefficient and amount of ACY diffused were higher in samples in comparison to pure ACY. Stability was found to be higher in dispersions. The results suggest that the study findings provided clear mechanical insights into the solubility and dissolution enhancement of ACY in PEG6000, and such findings could lay the platform for resolving the poor aqueous solubility issues in formulation development.
- 21 December 2016
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 18 (6) , 2085-2094
Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights
The dissolution and subsequent oral bioavailability of acyclovir (ACY) is limited by its poor aqueous solubility. An attempt has been made in this work to provide mechanistic insights into the solubility enhancement and dissolution of ACY by using the water-soluble carrier polyethylene glycol 6000 (PEG6000). Solid dispersions with varying ratios of the drug (ACY) and carrier (PEG6000) were prepared and evaluated by phase solubility, in vitro release studies, kinetic analysis, in situ perfusion, and in vitro permeation studies. Solid state characterization was done by powder X-ray diffraction (XRD), differential scanning calorimetry (DSC), and Fourier transform infrared (FTIR) analysis, and surface morphology was assessed by polarizing microscopic image analysis, scanning electron microscopy, atomic force microscopy, and nuclear magnetic resonance analysis. Thermodynamic parameters indicated the solubilization effect of the carrier. The aqueous solubility and dissolution of ACY was found to be higher in all samples. The findings of XRD, DSC, FTIR and NMR analysis confirmed the formation of solid solution, crystallinity reduction, and the absence of interaction between the drug and carrier. SEM and AFM analysis reports ratified the particle size reduction and change in the surface morphology in samples. The permeation coefficient and amount of ACY diffused were higher in samples in comparison to pure ACY. Stability was found to be higher in dispersions. The results suggest that the study findings provided clear mechanical insights into the solubility and dissolution enhancement of ACY in PEG6000, and such findings could lay the platform for resolving the poor aqueous solubility issues in formulation development.
- Open Access
- 1 January 2016
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 6 (4) , 194-200
Mechanistic insights into acyclovir-polyethylene glycol 20000 binary dispersions
Objective: The objective of this study is to provide a mechanistic insight into solubility enhancement and dissolution of acyclovir (ACY) by polyethylene glycol20000 (PEG20000). Materials and Methods: Solid dispersions with differing ratios of drug (ACY) and carrier (PEG20000) were prepared and evaluated by phase solubility, in vitro release studies, kinetic analysis, in situ perfusion, and in vitro permeation studies. Solid state characterization was also done by Powder X-Ray Diffraction (PXRD), Differential Scanning Calorimetry (DSC), Fourier Transform Infrared spectroscopy (FT-IR) analysis and surface morphology was assessed by Polarizing Microscopic Image (PMI) analysis, Scanning Electron Microscopy (SEM), Atomic Force Microscopy (AFM), and Nuclear Magnetic Resonance (NMR) analysis. Results: Thermodynamic parameters proved the solubilization effect of carrier. The aqueous solubility and dissolution of ACY were increased in all samples. Formation of solid solution, crystallinity reduction, and absence of interaction between drug and carrier was proved by XRD, DSC, and FTIR analysis. The particle size reduction and change in surface morphology were confirmed by SEM and AFM and analysis. The permeation coefficient and amount of drug diffused was higher in samples as compared to ACY. The stability was high in dispersions, and it was proved by NMR analysis. Conclusion: The mechanical insights into the enhancement of solubility and dissolution could be used as a platform to improve the aqueous solubility for other poor water soluble drugs.
- 1 January 2016
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 6 (4) , 194-200
Open AccessMechanistic insights into acyclovir-polyethylene glycol 20000 binary dispersions
Objective: The objective of this study is to provide a mechanistic insight into solubility enhancement and dissolution of acyclovir (ACY) by polyethylene glycol20000 (PEG20000). Materials and Methods: Solid dispersions with differing ratios of drug (ACY) and carrier (PEG20000) were prepared and evaluated by phase solubility, in vitro release studies, kinetic analysis, in situ perfusion, and in vitro permeation studies. Solid state characterization was also done by Powder X-Ray Diffraction (PXRD), Differential Scanning Calorimetry (DSC), Fourier Transform Infrared spectroscopy (FT-IR) analysis and surface morphology was assessed by Polarizing Microscopic Image (PMI) analysis, Scanning Electron Microscopy (SEM), Atomic Force Microscopy (AFM), and Nuclear Magnetic Resonance (NMR) analysis. Results: Thermodynamic parameters proved the solubilization effect of carrier. The aqueous solubility and dissolution of ACY were increased in all samples. Formation of solid solution, crystallinity reduction, and absence of interaction between drug and carrier was proved by XRD, DSC, and FTIR analysis. The particle size reduction and change in surface morphology were confirmed by SEM and AFM and analysis. The permeation coefficient and amount of drug diffused was higher in samples as compared to ACY. The stability was high in dispersions, and it was proved by NMR analysis. Conclusion: The mechanical insights into the enhancement of solubility and dissolution could be used as a platform to improve the aqueous solubility for other poor water soluble drugs.
- 9 October 2013
- Published by Taylor & Francis in Drug Delivery
- Vol. 21 (3) , 173-184
Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery
Novel LNCs (lipid nanocrystals) were developed with an aim to improve the solubility, stability and targeting efficiency of the model drug glibenclamide (GLB). PEG 20000, Tween 80 and soybean lecithin were used as polymer, surfactant and complexing agent, respectively. GLB nanocrystals (NCs) were prepared by precipitation process and complexed using hot and cold melt technique. The LNCs were evaluated by drug loading, saturation solubility (SL), optical clarity, in vitro dissolution, solid state characterization, in vivo and stability analysis. LNCs exhibited a threefold increase in SL and a higher dissolution rate than GLB. The percentage dissolution efficiency was found to decrease with increase in PEG 20000. The average particle size was in the range of 155–842 nm and zeta potential values tend to increase after complexation. X-ray powder diffractometry and differential scanning calorimetry results proved the crystallinity prevailed in the samples. Spherical shaped particles (In vivo study findings showed a decrease in drug concentration to pancreas in male Wistar rats. It can be concluded that LNCs are could offer enhanced solubility, dissolution rate and stability for poorly water soluble drugs. The targeting efficiency of LNCs was decreased and further membrane permeability studies ought to be carried out.
- 9 October 2013
- Published by Taylor & Francis in Drug Delivery
- Vol. 21 (3) , 173-184
Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery
Novel LNCs (lipid nanocrystals) were developed with an aim to improve the solubility, stability and targeting efficiency of the model drug glibenclamide (GLB). PEG 20000, Tween 80 and soybean lecithin were used as polymer, surfactant and complexing agent, respectively. GLB nanocrystals (NCs) were prepared by precipitation process and complexed using hot and cold melt technique. The LNCs were evaluated by drug loading, saturation solubility (SL), optical clarity, in vitro dissolution, solid state characterization, in vivo and stability analysis. LNCs exhibited a threefold increase in SL and a higher dissolution rate than GLB. The percentage dissolution efficiency was found to decrease with increase in PEG 20000. The average particle size was in the range of 155–842 nm and zeta potential values tend to increase after complexation. X-ray powder diffractometry and differential scanning calorimetry results proved the crystallinity prevailed in the samples. Spherical shaped particles (In vivo study findings showed a decrease in drug concentration to pancreas in male Wistar rats. It can be concluded that LNCs are could offer enhanced solubility, dissolution rate and stability for poorly water soluble drugs. The targeting efficiency of LNCs was decreased and further membrane permeability studies ought to be carried out.
- Open Access
- 1 June 2012
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 48 (2) , 243-255
Physicochemical characterization and in vitro dissolution behavior of olanzapine-mannitol solid dispersions
The objective of the present work is to study the dissolution behavior of olanzapine from its solid dispersions with mannitol. Solid dispersions were prepared by melt dispersion method and characterized by phase solubility studies, drug content and in vitro dissolution studies. The best releasing dispersions were selected from release data, dissolution parameters and their release profiles. Solid state characterization techniques like Fourier transform infrared (FT-IR) spectroscopy, X-ray diffractometry, differential scanning calorimetry, near-infrared and Raman spectroscopy were used to characterize the drug in selected dispersions. The dispersions were also evaluated by wettability studies and permeation studies. The results of phase solubility studies and the thermodynamic parameters indicated the spontaneity and solubilization effect of the carrier. The release study results showed greater improvement of drug release from solid dispersions compared to pure drug, and the release was found to increase with an increase in carrier content. The possible mechanism for increased release rate from dispersions may be attributed to solubilization effect of the carrier, change in crystal quality, phase transition from crystalline to amorphous state, prevention of agglomeration or aggregation of drug particles, change in surface hydrophobicity of the drug, and increased wettability and dispersability of the drug in dissolution medium. The suggested reasons for increased release rate from dispersions were found to be well supported by results of solid state characterization, wettability and permeation studies. The absence of any interaction between the drug and the carrier was also proved by FT-IR analysis.
- 1 June 2012
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 48 (2) , 243-255
Open AccessPhysicochemical characterization and in vitro dissolution behavior of olanzapine-mannitol solid dispersions
The objective of the present work is to study the dissolution behavior of olanzapine from its solid dispersions with mannitol. Solid dispersions were prepared by melt dispersion method and characterized by phase solubility studies, drug content and in vitro dissolution studies. The best releasing dispersions were selected from release data, dissolution parameters and their release profiles. Solid state characterization techniques like Fourier transform infrared (FT-IR) spectroscopy, X-ray diffractometry, differential scanning calorimetry, near-infrared and Raman spectroscopy were used to characterize the drug in selected dispersions. The dispersions were also evaluated by wettability studies and permeation studies. The results of phase solubility studies and the thermodynamic parameters indicated the spontaneity and solubilization effect of the carrier. The release study results showed greater improvement of drug release from solid dispersions compared to pure drug, and the release was found to increase with an increase in carrier content. The possible mechanism for increased release rate from dispersions may be attributed to solubilization effect of the carrier, change in crystal quality, phase transition from crystalline to amorphous state, prevention of agglomeration or aggregation of drug particles, change in surface hydrophobicity of the drug, and increased wettability and dispersability of the drug in dissolution medium. The suggested reasons for increased release rate from dispersions were found to be well supported by results of solid state characterization, wettability and permeation studies. The absence of any interaction between the drug and the carrier was also proved by FT-IR analysis.
- Open Access
- 1 January 2011
- Vol. 10 (1) , 13-24
Characterization of Olanzapine-Solid Dispersions
Aim: To enhance the aqueous solubility of olanzapine by using the Solid dispersion technique. Solid dispersions of olanzapine were prepared by the dispersion method using using PGS and SSG as carriers. Drug-carrier ratios such as 1 : 1, 1 : 2, 1 : 4, 1 : 6, 1: 8 and 1 : 10 were tried for optimization. Characterization was done by phase solubility, in-vitro release, saturation solubility, permeation, wettability, XRD and FTIR analysis. Solid dispersions showed higher solubility and an improved drug release profile than the pure drug. Solid dispersion and physical mixture with a drug-polymer ratio of 1 : 10 showed the best release profile in comparison with the other samples. Phase solubility results verified the solubilization effect of the carrier. XRD and NIR analysis confirmed the reduction of crystallinity in the samples. The release study findings were well supported by the results of wettability, saturation solubility and permeability studies. IR analysis substantiated the inertness of the carrier. It was concluded that pregelatinised starch (PGS) and sodium starch glycollate (SSG) could be utilized as effective carriers to improve the aqueous solubility of poorly soluble drugs.
- 1 January 2011
- Vol. 10 (1) , 13-24
Open AccessCharacterization of Olanzapine-Solid Dispersions
Aim: To enhance the aqueous solubility of olanzapine by using the Solid dispersion technique. Solid dispersions of olanzapine were prepared by the dispersion method using using PGS and SSG as carriers. Drug-carrier ratios such as 1 : 1, 1 : 2, 1 : 4, 1 : 6, 1: 8 and 1 : 10 were tried for optimization. Characterization was done by phase solubility, in-vitro release, saturation solubility, permeation, wettability, XRD and FTIR analysis. Solid dispersions showed higher solubility and an improved drug release profile than the pure drug. Solid dispersion and physical mixture with a drug-polymer ratio of 1 : 10 showed the best release profile in comparison with the other samples. Phase solubility results verified the solubilization effect of the carrier. XRD and NIR analysis confirmed the reduction of crystallinity in the samples. The release study findings were well supported by the results of wettability, saturation solubility and permeability studies. IR analysis substantiated the inertness of the carrier. It was concluded that pregelatinised starch (PGS) and sodium starch glycollate (SSG) could be utilized as effective carriers to improve the aqueous solubility of poorly soluble drugs.